Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous
J S Stenehjem1,2, K B Smeland1, K Murbraech3
1Department of Oncology, National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
Bone Marrow Transplantation
|December 20, 2016
Abstract
No abstract available in PubMed .

